APA (7th ed.) Citation

März, W., Wollschläger, H., Klein, G., Neiß, A., & Wehling, M. (1999). Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial). The American journal of cardiology, 84(1), . https://doi.org/10.1016/S0002-9149(99)00183-6

Chicago Style (17th ed.) Citation

März, Winfried, Helmut Wollschläger, Gernot Klein, Albrecht Neiß, and Martin Wehling. "Safety of Low-density Lipoprotein Cholesterol Reduction with Atorvastatin Versus Simvastatin in a Coronary Heart Disease Population (the TARGET TANGIBLE Trial)." The American Journal of Cardiology 84, no. 1 (1999). https://doi.org/10.1016/S0002-9149(99)00183-6.

MLA (9th ed.) Citation

März, Winfried, et al. "Safety of Low-density Lipoprotein Cholesterol Reduction with Atorvastatin Versus Simvastatin in a Coronary Heart Disease Population (the TARGET TANGIBLE Trial)." The American Journal of Cardiology, vol. 84, no. 1, 1999, https://doi.org/10.1016/S0002-9149(99)00183-6.